Rare diseases
Investigational molecules
Locations
Study of Isatuximab, Lenalidomide, and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma
NorwayStudy on Sotorasib for Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer and Comorbidities
NorwayStudy of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors
NorwayStudy on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren's Syndrome
NorwayStudy of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression
NorwayStudy on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
NorwayStudy on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment
NorwayStudy on the Safety and Efficacy of Viltolarsen for Boys with Duchenne Muscular Dystrophy
NorwayStudy on Tisagenlecleucel for High-Risk B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients with Minimal Residual Disease
NorwayStudy of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy
NorwayStudy on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Ulcerative Colitis
NorwayStudy on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer's Disease
NorwayTell us about your condition – we search every trial in Europe and connect you with the right site.
